Publication | Closed Access

Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway

Breast OncologyMedicineBreast Cancer CellsMatrix MetalloproteinasesCancer Cell BiologyCell-matrix Interactionβ-Catenin Signaling PathwayBreast CancerMatrix BiologyRadiation OncologyCancer BiologyCell BiologyTumor BiologyCancer Growth